Articles liés à Destabilization of Abnormal Methylation Enzymes to...
Destabilization of Abnormal Methylation Enzymes to Combat Cancer: The Nature’s Choice to Win the War on Cancer - Couverture souple
Synopsis
The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour Destabilization of Abnormal Methylation Enzymes to...
Image fournie par le vendeur
Destabilization of Abnormal Methylation Enzymes to Combat Cancer
Edité par
LAP LAMBERT Academic Publishing Jun 2020, 2020
ISBN 10 : 620266889X
ISBN 13 : 9786202668897
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points. 60 pp. Englisch. N° de réf. du vendeur 9786202668897
Acheter neuf
EUR 24,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
Destabilization of Abnormal Methylation Enzymes to Combat Cancer
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 620266889X
ISBN 13 : 9786202668897
Neuf
Kartoniert / Broschiert
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Kartoniert / Broschiert. Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: C. Liau MingDr. Ming C. Liau received Ph. D. in Biochemistry in 1966 from Baylor College of Medicine. He dedicated his entire life on cancer research. Dr. Kim is a cancer biologist with background in Angiogenesis and has been work. N° de réf. du vendeur 385948890
Acheter neuf
EUR 23,07
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
Destabilization of Abnormal Methylation Enzymes to Combat Cancer
Edité par
LAP LAMBERT Academic Publishing Jun 2020, 2020
ISBN 10 : 620266889X
ISBN 13 : 9786202668897
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 60 pp. Englisch. N° de réf. du vendeur 9786202668897
Acheter neuf
EUR 24,90
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Destabilization of Abnormal Methylation Enzymes to Combat Cancer : The Nature¿s Choice to Win the War on Cancer
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 620266889X
ISBN 13 : 9786202668897
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The therapeutic end point of destabilization of abnormal methylation enzymes is terminally differentiated cells. This end point is compatible with the end point on the therapy of hematological cancers. It can fit in on the therapy of hematological cancers, but it will not be easy for the acceptance on the therapy of solid cancers. In combination with surgery, or cytotoxic chemotherapy to pursue the end point of tumor disappearance is perhaps an easy way out. Different end points, however, have to be sought to legitimate differentiation therapy. End point of the disappearance of circulating cancer stem cells, or restoration of plasma/urine peptide ratios to those of healthy people are valid, but need careful studies before being accepted as valid end points. N° de réf. du vendeur 9786202668897
Acheter neuf
EUR 27,04
Expédition à EUR 60,54
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
Destabilization of Abnormal Methylation Enzymes to Combat Cancer | The Nature's Choice to Win the War on Cancer
Edité par
LAP LAMBERT Academic Publishing, 2020
ISBN 10 : 620266889X
ISBN 13 : 9786202668897
Neuf
Taschenbuch
Vendeur : preigu, Osnabrück, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. Destabilization of Abnormal Methylation Enzymes to Combat Cancer | The Nature's Choice to Win the War on Cancer | Ming C. Liau (u. a.) | Taschenbuch | 60 S. | Englisch | 2020 | LAP LAMBERT Academic Publishing | EAN 9786202668897 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu. N° de réf. du vendeur 118535813
Acheter neuf
EUR 23,25
Expédition à EUR 70
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 5 disponible(s)